000 01209 a2200337 4500
005 20250517114209.0
264 0 _c20170331
008 201703s 0 0 eng d
022 _a1756-1833
024 7 _a10.1136/bmj.i4728
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEmsley, Robin
245 0 0 _aPlacebo controls in clinical trials: concerns about use in relapse prevention studies in schizophrenia.
_h[electronic resource]
260 _bBMJ (Clinical research ed.)
_cSep 2016
300 _ai4728 p.
_bdigital
500 _aPublication Type: Journal Article; Video-Audio Media
650 0 4 _aAntipsychotic Agents
_xtherapeutic use
650 0 4 _aClinical Trials as Topic
_xethics
650 0 4 _aDrug and Narcotic Control
_xmethods
650 0 4 _aHumans
650 0 4 _aPlacebos
650 0 4 _aSchizophrenia
_xdrug therapy
650 0 4 _aSecondary Prevention
_xethics
700 1 _aFleischhacker, W Wolfgang
700 1 _aGalderisi, Silvana
700 1 _aHalpern, Lisa J
700 1 _aMcEvoy, Joseph P
700 1 _aSchooler, Nina R
773 0 _tBMJ (Clinical research ed.)
_gvol. 354
_gp. i4728
856 4 0 _uhttps://doi.org/10.1136/bmj.i4728
_zAvailable from publisher's website
999 _c26405879
_d26405879